Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects
Open Access
- 10 October 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (10) , 1736-1742
- https://doi.org/10.1038/sj.leu.2401906
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trialBritish Journal of Haematology, 1998
- Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Dose intensification in acute myloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's ATML9 studyBritish Journal of Haematology, 1996
- Autologous Bone Marrow Transplantation versus Intensive Consolidation Chemotherapy for Acute Myeloid Leukemia in ChildhoodNew England Journal of Medicine, 1996
- Acute leukemia in childrenCurrent Opinion in Hematology, 1996
- High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhoodThe Journal of Pediatrics, 1995
- CELLULAR PHARMACOLOGY AND OPTIMAL THERAPEUTIC CONCENTRATIONS OF 1‐β‐D‐ARABINOFURANOSYLCYTOSINE 5‘‐TRIPHOSPHATE IN LEUKEMIC BLASTS DURING TREATMENT OF REFRACTORY LEUKEMIA WITH HIGH‐DOSE 1‐β‐D‐ARABINOFURANOSYLCYTOSINEScandinavian Journal of Haematology, 1986
- High-Performance Liquid Chromatographic Analysis of the Semisynthetic Epipodophyllotoxins Teniposide and Etoposide Using Electrochemical DetectionJournal of Pharmaceutical Sciences, 1984
- Synchronization of the Mitotic Cycle in Acute LeukaemiaNature, 1969
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958